AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Anglo American, the London-based resources group, cannot afford to supply anti-retroviral drugs to all its HIV-AIDS infected workers in South Africa, the company medical department has announced.
Brian Brink, Anglo American's senior vice-president (medical) said the company's 14,000 senior staff would receive anti-retroviral treatment as part of their medical insurance, but that the provision of drug treatment for lower income employees was too expensive. About 21% of Anglo American's employees in South Africa are HIV positive. An anti-retroviral treatment costs about R1,500 (GBP110) a month.
Following the lead of Debswana, Botswana and De Beers' diamond company, other major Southern African companies were expected to foot the bill for ARVs (MRB April 01).
The SA government has indicated that cost is the main reason it will not go down the treatment route, and government and trade unions were ...